Glofitamab,Obinutuzumab,Tocilizumab
roche
['dlbcl']
a game changer for #dlbcl patients. from presenting the results at #ash22 with a publication in 
Cancer-dedicated research workforce @PeterMacCC. Committed to better treatments, care and cures for cancer